Acadia Healthcare (NASDAQ:ACHC) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a buy rating in a research report sent to investors on Thursday, MarketBeat reports. Deutsche Bank Aktiengesellschaft currently has $75.00 price target on the stock, up from their prior price target of $45.00.

A number of other research firms also recently weighed in on ACHC. Royal Bank of Canada dropped their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays lowered their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Finally, StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $75.44.

Acadia Healthcare Stock Up 0.8 %

Shares of NASDAQ ACHC opened at $40.66 on Thursday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $3.78 billion, a price-to-earnings ratio of 13.33, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The firm’s 50-day simple moving average is $45.39 and its 200 day simple moving average is $61.82.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 earnings per share. On average, research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of large investors have recently made changes to their positions in the company. SG Americas Securities LLC increased its stake in Acadia Healthcare by 435.6% during the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after purchasing an additional 14,824 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the period. TCW Group Inc. lifted its position in Acadia Healthcare by 63.8% in the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock valued at $4,247,000 after acquiring an additional 24,487 shares in the last quarter. Vaughan Nelson Investment Management L.P. increased its holdings in Acadia Healthcare by 67.9% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock worth $49,541,000 after purchasing an additional 296,625 shares in the last quarter. Finally, Fifth Third Wealth Advisors LLC acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $206,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.